Pardes Biosciences, Inc.
Pardes Biosciences, Inc.（PRDS）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · PRDS · 截至 2026年6月9日
活动摘要
买入笔数
7
P-Purchase only
卖出笔数
0
近12个月
买卖比
∞
Buy/Sell (by trades)
整体情绪
Pardes Biosciences, Inc.内部人在过去近12个月净买入股份，可能反映对公司前景的信心。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月9日
PRDS 季度内部人买卖趋势
PRDS 内幕交易卖出 · PRDS 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 9, 2026
近期内幕交易记录
PRDS 高管卖出股份 · PRDS 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| Aug 31, 2023 | Tananbaum James B. President and CEO · Director | Other | 1,000 | $0 | Form 4 |
| Aug 31, 2023 | Tananbaum James B. President and CEO · Director | Other | 16,813,146 | $2K | Form 4 |
| Aug 31, 2023 | WIGGANS THOMAS G CEO · Director | Other | 50,000 | $107K | Form 4 |
| Aug 31, 2023 | Varney Michael David Director | Other | 70,390 | $150K | Form 4 |
| Aug 31, 2023 | Lopatin Uri A Director | Other | 351,948 | $750K | Form 4 |
| Aug 31, 2023 | LOBELL J JAY Director | Other | 1,163,861 | $2.48M⚡ | Form 4 |
| Aug 31, 2023 | Lacy Elizabeth H. General Counsel, Secretary | Other | 211,169 | $450K | Form 4 |
| Aug 31, 2023 | HENSON HEIDI CFO | Other | 316,753 | $675K | Form 4 |
| Aug 31, 2023 | AUERBACH MARK Director | Other | 70,390 | $150K | Form 4 |
| Apr 5, 2023 | Foresite Capital Opportunity Management V, LLC 10 percent owner | Purchase | 773,952 | $1.16M⚡ | Form 4 |
| Apr 5, 2023 | Foresite Capital Management V, LLC 10 percent owner | Purchase | 773,952 | $1.16M⚡ | Form 4 |
| Dec 8, 2022 | Brusky Sean P. Chief Commercial Officer | Purchase | 21,000 | $25K | Form 4 |
| Dec 5, 2022 | WIGGANS THOMAS G CEO | Purchase | 12,500 | $14K | Form 4 |
| Dec 1, 2022 | Foresite Capital Management V, LLC Director | Purchase | 637,420 | $542K | Form 4 |
| Dec 2, 2022 | WIGGANS THOMAS G CEO | Purchase | 12,500 | $13K | Form 4 |
| Dec 1, 2022 | WIGGANS THOMAS G CEO | Purchase | 25,000 | $26K | Form 4 |
| Jul 19, 2022 | LOBELL J JAY Director | Other | 1,163,861 | — | Form 4 |
Tananbaum James B.
President and CEO · Director
日期
Aug 31
股数
1,000
均价
$0.00
总金额
$0
Tananbaum James B.
President and CEO · Director
日期
Aug 31
股数
16,813,146
均价
$0.00
总金额
$2K
Lacy Elizabeth H.
General Counsel, Secretary
日期
Aug 31
股数
211,169
均价
$2.13
总金额
$450K
Foresite Capital Opportunity Management V, LLC
10 percent owner
日期
Apr 5
股数
773,952
均价
$1.50
总金额
$1.16M ⚡
Foresite Capital Management V, LLC
10 percent owner
日期
Apr 5
股数
773,952
均价
$1.50
总金额
$1.16M ⚡
Foresite Capital Management V, LLC
Director
日期
Dec 1
股数
637,420
均价
$0.85
总金额
$542K
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 PRDS 内幕交易
PRDS 内幕交易
Pardes Biosciences, Inc.（PRDS）内幕交易数据来源于公司内部人（包括PRDS）提交的SEC Form 4申报文件。过去12个月内，0位内部人向SEC提交了交易申报。PRDS内部人近期主要在买入，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看Pardes Biosciences, Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
PRDS 内幕交易 · 5个问题Pardes Biosciences, Inc.（PRDS）的内部人包括高管和董事，如PRDS等。过去12个月内，0位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 9, 2026